Cargando…

CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia

Downregulation of suppressor of cytokine signalling-1 (SOCS1) is one of the vital reasons for JAK1-STAT3 pathway activation in acute myeloid leukaemia (AML). CUE domain-containing 2 (CUEDC2) was a novel interacting partner of SOCS1 and a positive correlation between the expression of CUEDC2 and SOCS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qing-Yun, Zhu, Yuan-Yuan, Liu, Yang, Wei, Fang, Tong, Yu-Xue, Cao, Jiang, Zhou, Ping, Niu, Ming-Shan, Li, Zhen-Yu, Zeng, Ling-Yu, Li, Feng, Xu, Kai-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039501/ https://www.ncbi.nlm.nih.gov/pubmed/29991678 http://dx.doi.org/10.1038/s41419-018-0812-6

Ejemplares similares

Myelopoiesis and Myeloid Leukaemogenesis in the Zebrafish
por: Forrester, A. Michael, et al.
Publicado: (2012)

The mechanism of radiation action in leukaemogenesis. The role of radiation in leukaemia development.
por: Haran-Ghera, N.
Publicado: (1967)

Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis
por: Kelly, Madison J., et al.
Publicado: (2019)

CUEDC2 controls osteoblast differentiation and bone formation via SOCS3–STAT3 pathway
por: Kim, Jung-Woo, et al.
Publicado: (2020)

Studies on Mouse Leukaemia. The Role of the Thymus in Leukaemogenesis by Cell-free Leukaemic Filtrates
por: Miller, J. F. A. P.
Publicado: (1960)

Studies on Mouse Leukaemia. Leukaemogenesis by Cell-free Filtrates Inoculated in Newborn and Adult Mice
por: Miller, J. F. A. P.
Publicado: (1960)

Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis
por: Williams, Christopher KO, et al.
Publicado: (2014)

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Asada, Shuhei, et al.
Publicado: (2018)

Studies on the Mechanisms of Chemical Leukaemogenesis
por: Dexter, T. M., et al.
Publicado: (1974)

Expression of CUEDC2 in colorectal cancer with different invasion and migration abilities
por: Hu, Shidong, et al.
Publicado: (2019)

Radiation leukaemogenesis: is virus really necessary?
por: Loutit, J. F., et al.
Publicado: (1978)

MUC1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism
por: Stroopinsky, Dina, et al.
Publicado: (2018)

Role of host endocrine status in murine leukaemogenesis.
por: Pierpaoli, W., et al.
Publicado: (1977)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

CUEDC2 modulates cardiomyocyte oxidative capacity by regulating GPX1 stability
por: Jian, Zhao, et al.
Publicado: (2016)

Immunodepression During Urethane and N-Nitrosomethylurea Leukaemogenesis in Mice
por: Parmiani, G., et al.
Publicado: (1971)

Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
por: Agathocleous, Michalis, et al.
Publicado: (2017)

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis
por: Han, Shuyan, et al.
Publicado: (2022)

CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway
por: Li, Feng, et al.
Publicado: (2017)

Downregulation of CUEDC2 prevents doxorubicin-induced cardiotoxicity in H9c2 cells
por: Zhang, Xianpu, et al.
Publicado: (2018)

CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
por: Sun, Longhua, et al.
Publicado: (2015)

How mutant p53 empowers Foxh1 fostering leukaemogenesis?
por: Amelio, Ivano
Publicado: (2019)

NDRG2 plays a pivotal role in ATLL leukaemogenesis by regulating the PTEN-mediated PI3K/AKT signalling pathway
por: Nakahata, Shingo, et al.
Publicado: (2014)

COVID-19 in persons with chronic myeloid leukaemia
por: Li, Weiming, et al.
Publicado: (2020)

The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL
por: Tavakoli Shirazi, Paniz, et al.
Publicado: (2019)

Long Noncoding RNA AROD Inhibits Host Antiviral Innate Immunity via the miR-324-5p–CUEDC2 Axis
por: Zhang, Zixiao, et al.
Publicado: (2023)

CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling
por: Wang, Aichun, et al.
Publicado: (2019)

CUEDC2 ablation enhances the efficacy of mesenchymal stem cells in ameliorating cerebral ischemia/reperfusion insult
por: Huang, Yan, et al.
Publicado: (2021)

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
por: Flex, Elisabetta, et al.
Publicado: (2014)

A novel epigenetic AML1‐ETO/THAP10/miR‐383 mini‐circuitry contributes to t(8;21) leukaemogenesis
por: Li, Yonghui, et al.
Publicado: (2017)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Enhancement of 7,12-dimethylbenz(a)anthracene leukaemogenesis in mice by neonatal injection of cortisone acetate.
por: Nishizuka, Y., et al.
Publicado: (1968)

Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity
por: van der Weyden, L, et al.
Publicado: (2013)

A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis
por: Sun, Xiao-Jian, et al.
Publicado: (2013)

RBFOX2 recognizes N(6)-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
por: Dou, Xiaoyang, et al.
Publicado: (2023)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML
por: Liu, Yu-xiao, et al.
Publicado: (2016)

The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan
por: Huang, Huai-Hsuan, et al.
Publicado: (2022)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

Cannot write session to /tmp/vufind_sessions/sess_osq1sv0c8msiqcpj545hgs09q6